24 February 2022

Now is the time to reduce global access inequalities to breast cancer treatment and management

The Lancet Breast Cancer Commission, a worldwide multidisciplinary team of leaders and patient advocates, published a few days ago a Comment article in the medical journal The Lancet calling for urgent action to ensure treatment equity for women with breast cancer no matter who they are and where they live. Fátima Cardoso, internationally renowned Director of the Breast Unit at the Champalimaud Foundation, is one of the authors and representative of the larger work group.

23 February 2022

Ana Luísa Correia awarded 2022 Pfizer Research Prize

Ana Luísa Correia joined the CF in December 2021. Prior to that, she worked for several years at the Basel University Hospital in Switzerland. During her stay there, she made breakthrough discoveries with potentially important therapeutic implications. She intends to pursue this line of work at the CF.

11 January 2022

Interview with Paulo Fidalgo

Up until the discovery of the bacteria Helicobacter pylori, in 1982, diseases of the stomach were thought to be due to excess gastric acidity. Today, we know that the vast majority of stomach cancers are caused by a sustained infection by Helicobacter, and that eradicating it is enough to drastically reduce stomach cancer risk. However, it is less known that, even after the bacteria’s eradication, unhealthy diets can promote the development of gastric cancers. And what almost nobody knows is that one of the main risk factors for stomach cancer is… salt.

06 January 2022

2021 Champalimaud Research Graduates

Francisco Romero

 

What was your thesis question and what did you find?

My original thesis question was ‘How do we read mental states from facial expressions?’ However, a few months after presenting it, my PhD project changed 180 degrees and the final question ended up being ‘How can deep learning help to understand collective behaviour in zebrafish?’ We found that deep learning is a very po

30 December 2021

Zoom-In on Champalimaud: The Reunion

But there’s more! During the interview, they also told us about great places to visit, cool music, fascinating podcasts and other discoveries they made this year. We couldn’t fit everything in the final cut, so we’ve listed their top recommendations below.

To view all 2021 individual episodes, tune in to the Zoom-In on Champalimaud YouTube playlist.

09 December 2021

Ana Luisa Correia

Nearly all types of cancers have the potential to form metastatic growths. However, the exact moment when metastasis emerges is highly variable. While some patients develop metastatic disease soon after the primary tumour appears, others can see decades pass before it happens. What is the source of this variability? 

03 November 2021

Zoom-In on Champalimaud - Episode 8

In this episode of the Zoom-In series, meet Maria Inês Romano. Curious about her work? Check out the Histopathology platform.

18 November 2021

Zoom-In on Champalimaud - Episode 9

In this episode of the Zoom-In series, meet Tânia Mesquita, C-Care Team Coordinator at the Champalimaud Clinical Centre.

09 November 2021

First-of-its-kind prize in Portugal awarded to the Champalimaud Foundation

The CF is one of the Portuguese institutions whose projects were chosen as recipients of this first edition, for their capacitation efforts at the level of clinical research.

30 October 2021

The BOUNCE Project: let’s talk about the resilience of women living with breast cancer

A diagnosis of breast cancer is not only an immediate life-threatening situation. It is also a psychological shock, whose repercussions can extend well past a patient’s recovery and jeopardise the leading of a normal life in the long run. However, not everyone reacts the same way to such a radical change of circumstances, which can imply invasive clinical interventions, radiotherapy and harsh chemotherapy regimens – and later strict surveillance to watch for recurrence.

Subscribe to Cancer
Loading
Please wait...